PBMs to enhance drug price transparency via TrumpRx
Several pharmacy benefit managers announced they will display TrumpRx prescription cash prices alongside plan benefit prices within their benefit tools to increase pricing transparency. The agreement aims to help consumers compare costs and identify savings, covering all drugs listed on TrumpRx irrespective of pricing type. This effort is part of a broader initiative by the Trump administration to lower prescription costs and improve transparency for American patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)